KEY WORD INDEX IN ENGLISH (2021;Volume 35)
2021-03-28
abrin(12):968
acetylcholine(2):153
acetylcholinesterase(2):115;(2):153
active immunization(12):968
acute kidney injury(4):282
acute stress disorder(7):521
adaptive immune response(12):948
addiction memory(8):581
adefovir(4):304
adipogenic induction(5):352
adipose-derived stem cells(5):352
ADP-ribosylation factor-like 6 interacting protein 1(8):594
adrenal(2):160
adverse outcome pathway(11):876
age-related macular degeneration(7):542
alternative test(12):896
amino acid site(12):912
amino acids(11):858
amyotrophic lateral sclerosis(11):844
animal model(2):131;(7):521;(8):616
antibiotic resistance genes(2):89
antibody library display technology(5):381
antibody technology(5):381
anti-drug antibodies(1):76
antitumor drugs(4):311
antiviral drugs(1):13
anxiety(8):616
apoptosis(4):282;(6):443,450;(7):513;(12):928
aquaporin 4(8):581
arctiin(8):608
arrhythmia(3):216
arsenic trioxide(7):550
asthma(6):480
astragaloside(4):304
atherosclerosis(5):400;(12):948
atrial fibrillation(3):216
autoimmune diseases(5):359
autophagy(2):145;(3):222;(12):928
behavior profile(7):521
betulinic acid(6):443
bibliometrics(9):714
bioequivalence(11):836
biomarker(3):234
biotechnology drugs(1):76
bi-specific T-cell engagers(7):522
blood pressure regulation(6):461
bortezomib(12):928
brain-derived neurotrophic factors(8):623
brain(8):640
brain ischemia(7):506
breast cancer(11):815
Caenorhabditiselegans(6):450
calcium signal(5):365
carbidopa(4):282
cell cycle(8):608
cell distribution(8):631
cell labeling(8):631
cell migration(8):631
cell polarization(1):50;(11):823
cell therapy(8):631
central nervous system(9):720
Chinese medicinal materials(2):95
cholinesterase(12):961
Chinese medicine compound(2):95
chronic liver diseases(1):57
chronic obstructive pulmonary diseases(6):480
circular dichroism(2):122
CiteSpace(9):714
clinical trials(1):13
cocaine(6):456
cognitive impairment(12):936
colorectal cancer(4):274
conditioned place preference(8):581
congenital immune response(12):948
coronavirus disease 2019(COVID-19)(1):13;(7):492;(8):574
corticosterone(6):419
cough(6):480
cyclin-dependent kinases(8):608
cyclin-dependent kinases inhibitor,P27(8):608
cyclins(8):608
cynomolgus monkey(3):200
cytochrome P450(4):296
cytochrome P450,CYP1A2(4):296
cytochrome P450,CYP2C9(4):296
cytochrome P450,CYP2D6(4):296
cytokine release syndrome(7):522
cytokines(7):558
development programming(2):160
developmental toxicity(2):160
dexmedetomidine(3):181
diabetes mellitus(3):168
diabetes mellitus,type 1(5):352
diabetic vascular complications(3):222
dihydroartemisinin(4):264
DILIsym model(5):390
dipeptide repeat proteins(11):844
DNA damage(5):344;(8):594;(11):815
DNA double strand breaks(3):210;(6):411
dorsal root ganglion(4):311
D-penicillamine(5):359
drug addiction(6):456
drug development(8):574
drug metabolizing enzymes(4):296
drug resistance(11):815
drug safety(2):95;(11):836
drug tolerance(1):76
drug toxicity(2):145
drug-induced liver injury(2):145;(5):390;(11):876
drugs(11):888
drusen(7):542
dynamic inhalation(12):936
dynorphin(11):851
electrode embedding method(5):373
electroencephalogram(5):373
electron transfer flavoprotein A(2):101
electrophysiology(12):936
endogenous cannabinoid system(8):623
endothelial nitric oxide synthase(7):493
endothelium dysfunction(7):493
enzyme kinetics(12):961
epigenetics(3):240;(5):335
ethology(8):616
fasting(11):836
fatigue(6):426
fatty acid(2):101
favipiravir(1):13
fentanyl derivatives(3):234
fibrosis(7):550
flow cytometry(3):210
frontotemporal dementia(11):844
fulvestrant(11):815
furanocoumarins(4):320
Gastrodiae Rhizoma(12):903
gene,C9orf72(11):844
gene,p53(3):210
gene,Pellino1(6):437
genetic toxicity(3):210;(6):411
glucose metabolism reprogramming(11):867
glucose metabolism(6):456
glycolysis(11):867
graft versus host disease(3):168
gut microbiome(2):89
H2AX(6):411
γ-H2AX(3):210
γ-H2AX assay(6):411
harmine derivative(6):450
healthy volunteers(11):836
heme oxygenase-1(3):169
hemophilia(1):18
hepatocellular carcinoma(2):101;(7):513
horizontal gene transfer(2):89
hormones(3):240
human brain organoids(11):829
human pluripotent stem cells(4):311
human serum albumin(2):122
hybridoma monoclonal antibody technology(5):381
5-hydroxytryptamine receptor(4):250
6-hydroxydopamine(12):903
hyperuricemia(8):601
hypothalamus-pituitary-adrenal axis(8):623
hypoxia(6):426
immunogenicity(1):76
immunosuppressant(1):50
indirectenzyme-linked immunosorbentassay(3):200
inescapable electric foot-shock model(1):35
inflammation(4):282;(11):867
inflammatory diseases(3):168
inhibitor of differentiation(4):274
insulin-like growth factor 1(4):258
integrated traditional Chinese and Western medi⁃cine(7):542
interaction(1):42
interferon-γ(11):823
intestinal injury(8):594
intestinal organoids(5):344
Intestine(12):922
in-vivotracing(8):631
ionizing radiation(5):344;(8):594
iron(9):720
ischemia/reperfusion injury(4):264
ischemic stroke(6):470
isoflurane(6):443
JS-K(7):513
large plant Rhodiola capsule(6):426
LC-MS/MS(2):108
lipids(11):858
liquid chromatography(5):335
liquid preparation(1):17
liver resection(2):131
liver X receptor ligands(5):400
liver X receptor(5):400
long noncoding RNA(3):216
long-term potentiation(6):419
lysosome(3):222
lysozyme(1):42
macrophages(4):289;(5):365
macrophages,RAW264.7(3):193
manganese(1):64;(9):720
mechanism-based inactivation(4):320
mechanosensitive ion channel(6):461
mesenchymal stem cells(3):168
mesolimbic dopamine system(11):851
metabolism(3):234
metabolites(11):858
metabolomics(11):858
metallothionein(2):122
metformin hydrochloride sustained-release tablets(11):836
metformin(5):344
methamphetamine(6):456
1-(4-methoxy)phenyl-9-butyl-β-carboline(6):450
N6-methyladenosine(1):57
N-methyl-D-aspartic acid receptor(6):419
N-methylhemeanthidine hydrochloride(1):50
methylation(5):335
microglia(6):437
microRNA(5):359
microRNA,miR-148a-3p(11):823
mitochondria(6):470;(11):844
mitochondrial calcium probe(5):365
mitophagy(8):587
molecular docking(1):42;(3):193
molecular initiating event(11):876
monoclonal antibody(3):200
morin(8):601
morphine(3):181;(6):456;(8):581
mouse(5):373;(5):352
mucosal injury(12):922
multiple myeloma(12):928
mutation(12):912
myocardial injury(4):264;(8):587
NAD(P)H oxidase 4(7):493
naltrexone(2):108
naltrexone-3-O-caprylate(2):108
nanobodies(9):714
nebulizer(1):17
nerve agents(2):115,153;(12):961
network pharmacology(3):193
neurogenesis(8):581
neuroinflammation(1):64
neuropathic pain(6):437
neurotoxicity(1):64;(4):311;(6):450;(8):640;(11):829
neurotransmitter(8):623;(11):851
neutralizing antibodies(7):492
new indications(8):574
nitrous oxide(12):936
NO donor(7):513
non-alcoholic fatty liver disease(3):169
non-clinical evaluation(1):71
noncoding RNA(7):550
Novichoks compounds(2):153
nuclear factor-erythroid 2-related factor 2(3):169
nucleic acids modification(5):335
ocular toxicity(11):888
oligosaccharides of Morinda officinalis(1):35
omics(7):542
opioid receptor(2):138
opioid receptor,κ(11):851
opioid receptor,μ(12):912
opioid-induced androgen deficiency(4):258
opioids(2):138
organophosphorus compounds(12):961
oridonin(11):815
β oxidation(2):101
oxidative damage(6):443
oxidative phosphorylation(11):867
oxidative stress(3):169;(4):264,282;(6):426;(11):829
pain emotion(11):851
paraquat(4):289;(7):558
Parkinson disease(12):903
passive immunization(12):968
pharmacokinetics(1):18;(2):108;(3):200;(4):320
phosphorylation of histone H3(3):210
physical dependence(3):181
physiologically-based pharmacokinetic model(5):390
Piezo channel(6):461
polyamines(12):922
polyporus polysaccharide(12):928
Polysaccharides(12):922
postoperative fatigue syndrome(2):131
post-transcriptional regulation(1):57
post-traumatic stress disorder(1):35;(7):521;(8):623
prediction(5):390
protein phosphatase 2A(7):513
protein synthesis(12):968
proteolysistargeting chimeras(PROTAC)(1):71
psychedelic(4):250
psychological dependence(3):181
pulmonary fibrosis(4):289;(7):558;(11):858
quantitative structure-activity relationship model(5):390
ranitidine hydrochloride(1):42
rats(5):373
γ ray radiation(4):296
reactivator(2):115;(12):961
recombinant activated factorⅦ(1):18
renal accumulation(4):304
reproductive toxicity(12):896
respiratory depression(2):138
reverse cholesterol transport(5):400
RhamnellagilgiticaMansf.et Melch.(3):193
rheumatoid arthritis(3):168,193
risk assessment(8):616,640;(11):876
risk management(2):95
ruscogenin(7):506
saikosaponin-d(3):169
sarpogrelate(4):282
sensory neurons(4):311
sesamin(7):493
severe acute respiratory syndrome coronavirus 2(7):492
signaling pathway(3):240;(4):289;(12):912
Sijunzi decoction(12):922
silica nanoparticles(2):122
single cell sequencing technology(5):381
single prolonged stress model(1):35
single-chain of variable fragments(7):522
Smads(4):289
small interfering RNA(8):594
spectrometry(1):42
sperm maturation(3):240
stemness(4):274
sub-scalp electrode(5):373
substance abuse detection(3):234
substance abuse(4):250
systemic lupus erythematosus(3):168
T cells(1):50
tandem mass spectrometry(5):335
testosterone(4):258
Th1 cells(11):823
total saponins fromTrilliumtschonoskiiMaxim(8):587
toxicity(4):320;(9):720
toxicogenomics(5):390
toxicokinetics(4):304
traditional Chinese medicine(11):867;(12):896,948
traditional Chinese medicine,safety(2):95
transcription factor EB(3):222
transforming growth factor-β(4):289
transgenic animal technology(5):381
transient receptor potential(6):480
tri-ortho-cresyl phosphate(11):829
triple negative breast cancer(8):608
tumor(11):867
UPLC-MS/MS(4):304
vincristine(6):437
vitamin E(7):493
VX(2):115
West Nile virus(3):200
xanthine oxidase(8):601
xenobiotics(2):160;(3):240
Yoda1(6):461
ZnO nanoparticles(8):640